Iomeron

Iomeprol, the active ingredient in Iomeron, is an iodinated non‑ionic contrast media presented as a solution for injection for intra‑arterial and intravenous use. It provides a high iodine concentration that attenuates X‑rays, improving image contrast and diagnostic accuracy in procedures such as angiography, computed tomography and urography.

GNH USA supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Iomeron is an iodinated non‑ionic contrast agent used to improve visualization of vascular and urinary structures during imaging procedures.

Angiography: enhances vessel delineation for diagnostic and interventional procedures. Computed tomography (CT) imaging: provides high‑contrast enhancement for better tissue differentiation. Urography: improves opacification of the urinary tract for detailed assessment.

Adverse reactions may occur after administration of Iomeron. Most are mild and transient, but rare serious events require immediate attention.

Common Side Effects: - Warm or flushing sensation during injection. - Metallic taste or mild nausea. - Headache or transient dizziness. - Mild hypotension or mild vomiting.

Serious or Rare Side Effects: - Anaphylactoid or severe allergic reaction. - Acute renal impairment, especially in patients with pre‑existing kidney disease. - Severe hypotension or cardiovascular collapse. - Seizures or neurological disturbances. - Pulmonary edema or respiratory distress.

Prior to using Iomeron, clinicians should evaluate patient risk factors and follow safe handling practices.

Renal function assessment: evaluate serum creatinine and eGFR before administration. Allergy history: screen for prior reactions to iodinated contrast agents. Thyroid disease: consider risk of iodine‑induced thyroid dysfunction. Pregnancy category B: use only when benefits outweigh potential risks. Pediatric considerations: adjust dose based on body weight and monitor closely. Store at ambient temperature: keep in original container, protect from light and moisture, and avoid freezing.

Iomeron may interact with other medicines, altering safety or efficacy.

Major Interactions (Avoid): - Metformin: risk of lactic acidosis in renal impairment; discontinue before contrast. - Nephrotoxic agents (e.g., aminoglycosides, amphotericin B): may exacerbate kidney injury. - Radioactive iodine therapy: iodine load can interfere with therapeutic efficacy.

Moderate Interactions (Monitor Closely): - Diuretics: may affect fluid balance and renal clearance. - ACE inhibitors or ARBs: monitor blood pressure and renal function. - NSAIDs: increase risk of contrast‑induced nephropathy. - Anticoagulants: watch for bleeding if invasive procedures follow contrast use.